AbbVie

Develops and delivers biopharmaceutical treatments

North Chicago, Illinois, United States

Visit Website View Jobs

About AbbVie

AbbVie develops and delivers medicines for serious health conditions, focusing on areas like immunology, oncology, virology, and neuroscience. Their products work by targeting specific diseases and conditions, providing healthcare providers and patients with effective treatment options. AbbVie stands out from competitors due to its significant investment in research and development, totaling $50 billion, which helps maintain a strong pipeline of new products. The company's goal is to improve patient care by addressing unmet medical needs while also committing to sustainability and responsible practices.

North Chicago, IllinoisHeadquarters
1888Year Founded
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Increased competition in immunology from new entrants like Light Horse Therapeutics.
Integration challenges with Nimble Therapeutics may delay expected benefits.
Partnership with MyHealthTeam may not boost pharma marketing as anticipated.

Differentiation

AbbVie invests heavily in R&D, with $50 billion spent to date.
The company has a strong presence in immunology, oncology, and neuroscience.
AbbVie offers a unique portfolio, including both pharmaceutical and aesthetic products.

Upsides

Acquisition of Nimble Therapeutics strengthens AbbVie's immunology pipeline.
AbbVie's focus on R&D ensures a steady pipeline of innovative treatments.
Partnerships with tech firms enhance AbbVie's R&D capabilities.